- Home
- FVRR vs LXEO Comparison
FVRR vs LXEO Comparison
Compare FVRR & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FVRR | LXEO |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.6M | 348.7M |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | FVRR | LXEO |
|---|---|---|
| Price | $8.64 | $2.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | $10.58 | ★ $20.30 |
| AVG Volume (30 Days) | 577.7K | ★ 1.9M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.81 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $654,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $22.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.31 | $2.56 |
| 52 Week High | $23.85 | $10.99 |
Technical Indicators
Market Signals| Indicator | FVRR | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 43.48 | 28.92 |
| Support Level | $8.31 | N/A |
| Resistance Level | $11.43 | $5.38 |
| Average True Range (ATR) | 0.23 | 0.23 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 27.43 | 14.60 |
Price Performance
Historical ComparisonAbout FVRR Fiverr International Ltd. no par value
Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.